EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION    
 
Services How to use the platform Build a poster MANAGE ORDERS FAQs Contact HOMEPAGE
 
 
   
Discussion forum - 49th ERA-EDTA Congress
    Topic - Renal development / Cystic diseases

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 7
Visits: 771
Title: A NOVEL PPAR GAMMA AGONIST DJ5 RETARDS CYST GROWTH AND PRESERVES KIDNEY FUNCTION IN A RAT POLYCYSTIC KIDNEY DISEASE MODEL
Authors: Xueqi Wang ,
Centre: Shanghai Changzheng Hospital, University Hospital Zurich

You must be registered to reply or comment.

A NOVEL PPAR GAMMA AGONIST DJ5 RETARDS CYST GROWTH AND PRESERVES KIDNEY FUNCTION IN A RAT POLYCYSTIC KIDNEY DISEASE MODEL

Xueqi Wang
Thread initiator
Subspeciality
Reg: 5/9/2012 11:23:00 PM

 Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 5/9/2012 11:23:00 PM 
     
You must be registered to reply or comment.




Most viewed poster for this congress
Poster: 424
Visits: 2636
Title: Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors: Giuseppe Coppolino ,
Centre: Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy


Poster most viewed in this topic
Poster: 2
Visits: 1203
Title: DELETIONS OF SIX1 AND UPK3A MAY CONTRIBUTE TO A RENAL PHENOTYPE IN SYNDROMAL PATIENTS
Authors: Albertien van Eerde , Ellen van Binsbergen1, Yvette Konijnenberg2, Merel C. Maiburg1, Klaske D. Lichtenbelt1, Peter G.J. Nikkels3, Jasper vd Smagt1, Kirsten Y.Renkema1, Jacques C. Giltay1, Tom P.V.M. de Jong2, Marc R. Lilien2, Nine V.A.M. Knoers1
Centre: UMC Utrecht, The Netherlands: 1 Department of Medical Genetics, 2 Paediatric Renal Center, 3 Department of Pathology


 View Poster Gallery
 Back to congress home
 Other Congresses


 
 
  About us  |  Terms and Conditions  |  Special Access